LSL Pharma Group Inc News - LSL

LSL Pharma Group Announces a Combination of Private Placements for Maximum Aggregate Gross Proceeds of $8 Million

Up to $3.5 M in cash proceedsUp to $4.5 M in debts conversion Proceeds to be used to further expand production...

LSL Pharma Group Announces an Extension of its Convertible Debentures Offering

BOUCHERVILLE, Québec, Jan. 08, 2024 (GLOBE NEWSWIRE) -- LSL Pharma Group Inc. (TSXV: LSL) – (the...

LSL Pharma Group Announces Closing of Second Tranche of Convertible Debentures Offering

BOUCHERVILLE, Québec, Dec. 08, 2023 (GLOBE NEWSWIRE) -- LSL Pharma Group Inc. (TSXV: LSL) – (the...

LSL Pharma Group Appoints Luc Mainville as Chief Financial Officer

BOUCHERVILLE, Quebec, Dec. 04, 2023 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC (TSXV: LSL) ("the Company" or...

LSL Pharma Group Announces its Results for the Third Quarter of Fiscal 2023

Revenues of $2.5M, up 25% over the last two quarters of the year;Gross margin of 18.6%, up sharply on last...

LSL Pharma Group Announces Closing of First Tranche of Convertible Debentures Offering

BOUCHERVILLE, Québec, Nov. 01, 2023 (GLOBE NEWSWIRE) -- LSL Pharma Group Inc. (TSXV: LSL) – (the...

Groupe LSL Pharma Announces New Orders with an Annual Revenue Potential in Excess of $2.6 Million

BOUCHERVILLE, Quebec, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Groupe LSL Pharma Inc. (TSXV: LSL) – (“the Company”...

LSL Pharma Group Announces Exclusive Distribution Agreement With Fera Pharmaceuticals to Alleviate Drug Shortage in U.S. Hospitals

BOUCHERVILLE, Québec, Oct. 18, 2023 (GLOBE NEWSWIRE) -- LSL Pharma Group Inc. (TSXV: LSL), (the...

LSL Pharma Group Engages Paradox as Investor Relations Services Provider

BOUCHERVILLE, Québec, Oct. 06, 2023 (GLOBE NEWSWIRE) -- LSL Pharma Group Inc. (TSXV: LSL) – (the...

LSL Pharma Group Announces Brokered Private Placement of Convertible Debentures of Up to $4,000,000

BOUCHERVILLE, Québec, Sept. 21, 2023 (GLOBE NEWSWIRE) -- LSL Pharma Group Inc. (TSXV: LSL) – (the...

LSLPharma Group Announces Its Second Quarter Results

43.5% revenue increase to $2.0 millionGross margin of 34%, up significantly from (23%) last year and 19% in the...

Groupe LSL Pharma Update on Increased Production Capacity and Anticipated Sales Growth

BOUCHERVILLE, Quebec, June 20, 2023 (GLOBE NEWSWIRE) -- GROUPE LSL PHARMA INC (TSXV: LSL) - Groupe LSL Pharma...

LSL Group Closes a Complementary and Final Private Placement of $145,000.10 to Its Reverse Takeover

BOUCHERVILLE, Quebec, March 14, 2023 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV : LSL) – LSL Pharma...

Closing of the Reverse Takeover Transaction With Laboratoire LSL Inc.

BOUCHERVILLE, Québec, Feb. 27, 2023 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV : LSL) – LSL Pharma...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

LSL Pharma Group Inc (LSL)

Empower your portfolio: Real-time discussions and actionable trading ideas.

LSL News

LSL Pharma Group Announces a Combination of Private Placements for Maximum Aggregate Gross Proceeds of $8 Million

LSL Pharma Group Announces an Extension of its Convertible Debentures Offering

LSL Pharma Group Announces Closing of Second Tranche of Convertible Debentures Offering

LSL Pharma Group Appoints Luc Mainville as Chief Financial Officer

LSL Pharma Group Announces its Results for the Third Quarter of Fiscal 2023

LSL Pharma Group Announces Closing of First Tranche of Convertible Debentures Offering

Groupe LSL Pharma Announces New Orders with an Annual Revenue Potential in Excess of $2.6 Million

LSL Pharma Group Announces Exclusive Distribution Agreement With Fera Pharmaceuticals to Alleviate Drug Shortage in U.S. Hospitals

LSL Pharma Group Engages Paradox as Investor Relations Services Provider

LSL Pharma Group Announces Brokered Private Placement of Convertible Debentures of Up to $4,000,000

LSLPharma Group Announces Its Second Quarter Results

Groupe LSL Pharma Update on Increased Production Capacity and Anticipated Sales Growth

LSL Group Closes a Complementary and Final Private Placement of $145,000.10 to Its Reverse Takeover

Closing of the Reverse Takeover Transaction With Laboratoire LSL Inc.

LSL Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

LSL Pharma Group Inc (LSL) News

LSL Pharma Group Inc (LSL)

Empower your portfolio: Real-time discussions and actionable trading ideas.

LSL News

LSL Pharma Group Announces a Combination of Private Placements for Maximum Aggregate Gross Proceeds of $8 Million

LSL Pharma Group Announces an Extension of its Convertible Debentures Offering

LSL Pharma Group Announces Closing of Second Tranche of Convertible Debentures Offering

LSL Pharma Group Appoints Luc Mainville as Chief Financial Officer

LSL Pharma Group Announces its Results for the Third Quarter of Fiscal 2023

LSL Pharma Group Announces Closing of First Tranche of Convertible Debentures Offering

Groupe LSL Pharma Announces New Orders with an Annual Revenue Potential in Excess of $2.6 Million

LSL Pharma Group Announces Exclusive Distribution Agreement With Fera Pharmaceuticals to Alleviate Drug Shortage in U.S. Hospitals

LSL Pharma Group Engages Paradox as Investor Relations Services Provider

LSL Pharma Group Announces Brokered Private Placement of Convertible Debentures of Up to $4,000,000

LSLPharma Group Announces Its Second Quarter Results

Groupe LSL Pharma Update on Increased Production Capacity and Anticipated Sales Growth

LSL Group Closes a Complementary and Final Private Placement of $145,000.10 to Its Reverse Takeover

Closing of the Reverse Takeover Transaction With Laboratoire LSL Inc.

LSL Discussion

Your Recent History